Literature DB >> 23110256

Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.

Stephanie J Wallace1, Jian Li, Roger L Nation, Ben J Boyd.   

Abstract

The characterization of encapsulation efficiency and in vitro drug release from nanoparticle-based formulations often requires the separation of nanoparticles from unencapsulated drug. Inefficient separation of nanoparticles from the medium in which they are dispersed can lead to inaccurate estimates of encapsulation efficiency and drug release. This study establishes dynamic light scattering as a simple method for substantiation of the effectiveness of the separation process. Colistin-loaded liposomes, as an exemplar nano-sized delivery particle, were diluted to construct a calibration curve relating the amount of light scattering to liposome concentration. Dynamic light scattering revealed that, in the case of ultracentrifugation and centrifugal ultrafiltration, approximately 2.9% of the total liposomes remained in supernatants or filtrates, respectively. In comparison, filtrates obtained using pressure ultrafiltration contained less than 0.002% of the total liposomes from the formulation. Subsequent release studies using dialysis misleadingly implied a slow release of colistin over >48 h. In contrast, pressure ultrafiltration revealed immediate equilibration to the equilibrium distribution of colistin between the liposome and aqueous phases upon dilution. Pressure ultrafiltration is therefore recommended as the optimal method of choice for studying release kinetics of drug from nanomedicine carriers.

Entities:  

Year:  2012        PMID: 23110256      PMCID: PMC3482165          DOI: 10.1007/s13346-012-0064-4

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  25 in total

1.  PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties.

Authors:  K Avgoustakis; A Beletsi; Z Panagi; P Klepetsanis; A G Karydas; D S Ithakissios
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

2.  Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides.

Authors:  Adrià Clausell; Maria Garcia-Subirats; Montserrat Pujol; M Antonia Busquets; Francesc Rabanal; Yolanda Cajal
Journal:  J Phys Chem B       Date:  2007-01-25       Impact factor: 2.991

3.  Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation.

Authors:  Maurizio Ricci; Stefano Giovagnoli; Paolo Blasi; Aurelie Schoubben; Luana Perioli; Carlo Rossi
Journal:  Int J Pharm       Date:  2006-01-24       Impact factor: 5.875

4.  Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.

Authors:  Stephanie J Wallace; Jian Li; Craig R Rayner; Kingsley Coulthard; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

5.  A novel in vitro release method for submicron sized dispersed systems.

Authors:  N Chidambaram; D J Burgess
Journal:  AAPS PharmSci       Date:  1999

6.  In vitro evaluation of enrofloxacin-loaded MLV liposomes.

Authors:  Ali Demir Sezer; Jülide Akbuğa; Ahmet Levent Baş
Journal:  Drug Deliv       Date:  2007-01       Impact factor: 6.419

7.  Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Richard J Prankerd; Tony Velkov; Ben J Boyd
Journal:  J Phys Chem B       Date:  2010-04-15       Impact factor: 2.991

8.  Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations.

Authors:  Michael J W Johnston; Katarina Edwards; Goran Karlsson; Pieter R Cullis
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

9.  Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.

Authors:  E H Herman; A Rahman; V J Ferrans; J A Vick; P S Schein
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

10.  An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride.

Authors:  N S Magalhaes; H Fessi; F Puisieux; S Benita; M Seiller
Journal:  J Microencapsul       Date:  1995 Mar-Apr       Impact factor: 3.142

View more
  28 in total

1.  Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes.

Authors:  Shengfu Yi; Cong Zhang; Junjie Hu; Yan Meng; Liang Chen; Huifan Yu; Shan Li; Guihong Wang; Guohua Zheng; Zhenpeng Qiu
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

2.  Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Richard J Prankerd; Ben J Boyd
Journal:  J Pharm Sci       Date:  2012-05-23       Impact factor: 3.534

Review 3.  Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Authors:  Darren Michael Moss; Marco Siccardi
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 4.  Improved delivery of poorly soluble compounds using nanoparticle technology: a review.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

Review 5.  Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective.

Authors:  Deepak Solomon; Nilesh Gupta; Nihal S Mulla; Snehal Shukla; Yadir A Guerrero; Vivek Gupta
Journal:  AAPS J       Date:  2017-09-18       Impact factor: 4.009

6.  Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles.

Authors:  Chinmay G Hiremath; Geetha B Heggnnavar; Mahadevappa Y Kariduraganavar; Murigendra B Hiremath
Journal:  Prog Biomater       Date:  2019-06-13

7.  Solid Phase Extraction as an Innovative Separation Method for Measuring Free and Entrapped Drug in Lipid Nanoparticles.

Authors:  Alexis Guillot; Anne-Claude Couffin; Xavier Sejean; Fabrice Navarro; Markus Limberger; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-07-23       Impact factor: 4.200

8.  Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments.

Authors:  Amir Maghrabia; Mariza Boughdady; Mahasen Meshali
Journal:  Int J Nanomedicine       Date:  2021-08-28

9.  Stable isotope method to measure drug release from nanomedicines.

Authors:  Sarah Skoczen; Scott E McNeil; Stephan T Stern
Journal:  J Control Release       Date:  2015-10-24       Impact factor: 9.776

10.  In Vitro Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges.

Authors:  Jie Shen; Diane J Burgess
Journal:  Drug Deliv Transl Res       Date:  2013-10-01       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.